Comments

Cellectar Biosciences Stock Price, Quotes and Forecasts

Q: What sector and industry does Cellectar Biosciences (CLRB) operate in?

Cellectar Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CLRBNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$9.70

0.778.57%

At close: -

$9.51

-0.19-1.96%

After Hours: 5:01 PM EDT

Cellectar Biosciences Inc is expected to split Tuesday, June 24, 2025 with a ratio of 1:30

Cellectar Biosciences (CLRB) Forecast

News Earnings Cellectar Biosciences (CLRB) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Cellectar Biosciences Stock Price, Quotes and Forecasts | NASDAQ:CLRB | Benzinga

Explore Cellectar Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CLRB.

Open	$8.55
Close	$9.70
Volume / Avg.	179.67K / 395.57K
Day Range	$8.30 - $9.85
52 Wk Range	6.72 - 94.50
Market Cap	$438.22M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	3.16%
Days to Cover	2.18

Recent News

Why Cheetah Mobile Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Crude Oil Falls Over 1%; ISM Services PMI Tumbles In May

Avi Kapoor

What's Behind Cellectar Biosciences' Stock Surge? FDA Update Explained

Cellectar's Iopofosine I 131 earned FDA breakthrough therapy designation for relapsed Waldenstrom macroglobulinemia following strong trial data.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$8.55
Close	$9.70
Volume / Avg.	179.67K / 395.57K
Day Range	$8.30 - $9.85
52 Wk Range	6.72 - 94.50
Market Cap	$438.22M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	3.16%
Days to Cover	2.18

About Cellectar Biosciences Inc

Sector

Health Care

Industry

Biotechnology

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discov...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cellectar Biosciences (CLRB) stock?

You can purchase shares of Cellectar Biosciences (NASDAQ:CLRB) through any online brokerage.

View our list of the best stock brokerages

Who are Cellectar Biosciences (CLRB) competitors?

Other companies in Cellectar Biosciences’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Precigen (NASDAQ:PGEN), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC) and aTyr Pharma (NASDAQ:ATYR).

What is the forecast, or price target, for Cellectar Biosciences (CLRB) stock?

Cellectar Biosciences has a consensus price target of $16.00.

What is the current price for Cellectar Biosciences (CLRB)?

The stock price for Cellectar Biosciences (NASDAQ: CLRB) is $9.51 last updated June 24, 2025 at 5:01 PM EDT.

Does Cellectar Biosciences (CLRB) pay a dividend?

There are no upcoming dividends for Cellectar Biosciences.

When is Cellectar Biosciences (NASDAQ:CLRB) reporting earnings?

Cellectar Biosciences’s Q2 earnings are confirmed for Tuesday, August 12, 2025.

Is Cellectar Biosciences (CLRB) going to split?

There is no upcoming split for Cellectar Biosciences.

What sector and industry does Cellectar Biosciences (CLRB) operate in?

Cellectar Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.